Seqens Seqens

X

Find the latest Drugs in Development and Pipeline Prospector News of Bioclinica.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Bioclinica
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
685 U.S. Highway 202/206, 2nd Floor Bridgewater, NJ 08807-1774
Telephone
Telephone
1-267-757-3000

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

left grey arrow
right gray arrow

Details:

Under the terms of the agreement, Direct Biologics will leverage Bioclinica’s Interactive Response Technology (IRT) for their EXIT COVID-19 study, a multi-center FDA phase II clinical trial for the use of ExoFlo™ to treat COVID-19 acute respiratory distress syndrome (ARDS).


Lead Product(s): DB-001

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: ExoFlo

Highest Development Status: Phase IIProduct Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Direct Biologics

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership September 09, 2020

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY